Metraipolis › archive › dc_69fd665eed48

Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42466442
DOI
10.1177/17562848261463601
License (as archived)
solo-consultazione
Archived
2026-10-18T07:12:59.308Z
SHA-256 of the archived text
f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f
Stable URL of this page
https://metraipolis.com/documento/dc_69fd665eed48

How to cite

Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442 — Europe PMC (en), https://europepmc.org/article/MED/42466442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69fd665eed48 (Metraipolis archive dc_69fd665eed48, sha256 f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f)
BibTeX
@misc{dc69fd665eed48,
  title = {Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42466442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69fd665eed48; sha256 f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466442. Agents can read the archived copy with the MCP tool read_document.